Lamotrigine | EP | Reference Standards | EDQM | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Lamotrigine
EDQM

PharmaCompass Sponsored Ads

Contact Supplier

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

Contact Supplier

dmfs-not-supported-m-2025-05-19

Chirogate is a professional Prostaglandin manufacturer.

Contact Supplier

Temad- We think of world-class quality.

Contact Supplier

jdmfs-not-supported-m-2025-04-28

Lamotrigine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

77 API Suppliers, 33 USDMF, 22 CEP/COS, 5 JDMF, 22 EU WC, 9 KDMF, 21 NDC API, 39 Listed Suppliers, $ API Reference Price

77 API Suppliers
33 USDMF
22 CEP/COS
5 JDMF
22 EU WC
9 KDMF
21 NDC API
39 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

INTERMEDIATES

18 Intermediate Suppliers

18 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1067 FDF Dossiers, 230 FDA Orange Book, 597 Europe, 38 Canada, 58 Australia, 72 South Africa, 72 Listed Dossiers

1067 FDF Dossiers
230 FDA Orange Book
597 Europe
38 Canada
58 Australia
72 South Africa
72 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG, TABLET;ORAL - 150MG, TABLET;ORAL - 200MG, TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 25MG, TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 100MG
TABLET;ORAL - 150MG
TABLET;ORAL - 200MG
TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 25MG
TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 10 Evonik, 5 Rochem International Inc, 23 SPI Pharma, 8 DKSH, 1 Pharm-RX Chemical, 8 Faran Shimi Pharmaceutical, 10 Boai NKY Pharmaceuticals Ltd, 9 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 8 Actylis, 3 Aeon Procare, 3 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 38 BASF, 1 Bioplus Life Sciences, 1 Clariant, 16 Corel Pharma Chem, 7 DFE Pharma, 4 Doshion Polyscience, 1 Finar, 13 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 12 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 40 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 20 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 5 Novo Excipients, 5 Pharmatrans-Sanaq, 9 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 23 Roquette, 14 Seppic, 9 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 2 Ulanqab Kema New Material, 3 Valens Pharmachem, 5 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

102 Fillers, Diluents & Binders, 81 Coating Systems & Additives, 50 Disintegrants & Superdisintegrants, 47 Direct Compression, 45 Controlled & Modified Release, 44 Taste Masking, 34 Granulation, 33 Solubilizers, 28 Thickeners and Stabilizers, 25 Film Formers & Plasticizers, 24 Lubricants & Glidants, 22 Chewable & Orodispersible Aids, 20 Co-Processed Excipients, 17 Parenteral, 15 Topical, 7 API Stability Enhancers, 7 Emulsifying Agents, 7 Rheology Modifiers, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 5 Empty Capsules, 4 Vegetarian Capsules

102 Fillers, Diluents & Binders
81 Coating Systems & Additives
50 Disintegrants & Superdisintegrants
47 Direct Compression
45 Controlled & Modified Release
44 Taste Masking
34 Granulation
33 Solubilizers
28 Thickeners and Stabilizers
25 Film Formers & Plasticizers
24 Lubricants & Glidants
22 Chewable & Orodispersible Aids
20 Co-Processed Excipients
17 Parenteral
15 Topical
7 API Stability Enhancers
7 Emulsifying Agents
7 Rheology Modifiers
5 Surfactant & Foaming Agents
5 Coloring Agents
5 Empty Capsules
4 Vegetarian Capsules

DIGITAL CONTENT

42 News #PharmaBuzz

42 News #PharmaBuzz

GLOBAL SALES INFORMATION

4 US Medicaid Prescriptions, 225 Regulatory FDF Prices, 10 Annual Reports

4 US Medicaid Prescriptions
225 Regulatory FDF Prices
10 Annual Reports

MARKET PLACE

11 APIs, 5 FDF Dossiers

11 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 US Patents, 6 Health Canada Patents

6 US Patents
6 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 8 Others

4 EDQM
8 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 131 Xls

Filters

Reset all filters

Filters

FILTER :

filter Order Code Reset all filters

4 All

01 1Y0001030

02 1Y0001031

03 1Y0001032

04 1Y0001085

filter CAS Number Reset all filters

4 All

01 150-45-3

02 384057-84-1

filter Reference Standard Reset all filters

4 All

01 1Lamotrigine

02 1Lamotrigine for peak identification

03 1Lamotrigine for system suitability

04 1Lamotrigine impurity E

IOL Lamotrigine

Product Main Page

01

EDQM, Council of Europe

Lamotrigine for system suitability

STLE Annual Meeting

Not Confirmed

01

EDQM, Council of Europe

STLE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Lamotrigine for system suitability

CAS Number : 84057-84-1

Quantity Per Vial : 10 mg

Sale Unit : 1

Order Code : Y0001085

Batch No : 2

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

EDQM, Council of Europe

Lamotrigine for peak identification

STLE Annual Meeting

Not Confirmed

02

EDQM, Council of Europe

STLE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Lamotrigine for peak identification

CAS Number : 84057-84-1

Quantity Per Vial : 20 mg

Sale Unit : 1

Order Code : Y0001031

Batch No : 1

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

EDQM, Council of Europe

Lamotrigine

STLE Annual Meeting

Not Confirmed

03

EDQM, Council of Europe

STLE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Lamotrigine

CAS Number : 84057-84-1

Quantity Per Vial : 10 mg

Sale Unit : 1

Order Code : Y0001030

Batch No : 1

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

EDQM, Council of Europe

Lamotrigine impurity E

STLE Annual Meeting

Not Confirmed

04

EDQM, Council of Europe

STLE Annual Meeting

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Lamotrigine impurity E

CAS Number : 50-45-3

Quantity Per Vial : 15 mg

Sale Unit : 1

Order Code : Y0001032

Batch No : 1

Price (€) : 79

Storage : +5°C ± 3°C

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!